<DOC>
	<DOCNO>NCT01735305</DOCNO>
	<brief_summary>Antiplatelet therapy cornerstone prevention atherothrombosis patient coronary artery disease ( CAD ) . However , efficacy safety antiplatelet therapy vary due ethnic and/or individual variability . The aim OPT-CAD study demonstrate contemporary status outcome antiplatelet therapy Chinese CAD patient , explore predictor ischemic bleed event cohort.Patients 18 year old diagnose CAD receive antiplatelet therapy prospectively enrol national wide , non-intervention registry . All medication laboratory test physician discretion .</brief_summary>
	<brief_title>Optimal Antiplatelet Therapy Chinese Patients With Coronary Artery Disease</brief_title>
	<detailed_description>Antiplatelet therapy cornerstone prevention atherothrombosis patient coronary artery disease ( CAD ) . However , efficacy safety antiplatelet therapy vary due ethnic and/or individual variability . The aim OPT-CAD study demonstrate contemporary status outcome antiplatelet therapy Chinese CAD patient , explore predictor ischemic bleed event cohort.Patients 18 year diagnose CAD receive antiplatelet therapy prospectively enrol national wide , non-intervention registry . All medication laboratory test physician discretion .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Inclusion criterion : 1 . Clinical diagnosis coronary heart disease 2 . Age &gt; = 18 year old 3. receive antiplatelet agent 4 . Informed write consent sign 1 . With severe disease life expectancy 6 month less 2 . Difficult attain followup situation judge researcher ( travel , speech mental disorder , etc . ) 3 . Taking part interventional clinical research</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Coronary Artery Disease</keyword>
	<keyword>antiplatelet therapy</keyword>
</DOC>